SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Anthony @ Equity Investigations, Dear Anthony,
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: gbh who wrote (54960)4/23/2000 4:21:00 PM
From: Anthony@Pacific  Read Replies (1) of 122087
 
That drug could have added approximately a max of 2 billion a year in revenues to a compnay that already does 20-22 billion the increase would have been nice but ..it certainly doenst warranta 30 billion dollar haircut/../

I have seen companies announce a 2 million dollar increase in revnue and seen the stocks run up more than a billion in mkt cap

and yes all analysts are paid on stocks their firms are buying pre report and selling pre -downgrade..irrespective of what they publicly say..
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News